4.2 Hormonal medical treatments Hormonal medical treatments for endometriosis-associated infertility target the endocrine pathogenetic mechanisms of the disease, aiming to block menstruation through inhibition of the hypothalamus-pituitary-ovary (HPO) axis or induction of pseudodecidualization with consequent amenorrhea, thereby impairing the progression of endometriotic implants ( GnRH agonists (goserelin, leuprolide, nafarelin, buserelin, triptorelin) downregulate pituitary GnRH receptors, leading to hypoestrogenism and amenorrhea, which results in regression of endometriotic lesions and improvement in pain symptoms
Atherosclerosis across 4000 years of human history: the Horus study of four ancient populations
Avoid mega-dosing without medical supervision, and remember that more is not necessarily betterthe body's absorption capacity is limited, and excess is simply excreted
That is, the group that initially got Eriomin took it for 12 weeks, then stopped for a two-week washout period, before taking the placebo for 12 weeks and vice-versa for the other group (placebo first, then Eriomin)
Afterward, well provide detailed guidelines to ensure optimal healing and results
It is expected that Finland research in animal models using both peptides would indicate greater benefits without significantly raising side effects
